Steven Glazer
Chief Tech/Sci/R&D Officer at Glazer Consulting Holding ApS
Steven Glazer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Glazer Consulting Holding ApS | Chief Tech/Sci/R&D Officer | - | - |
MonTa Biosciences ApS
 MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Chief Tech/Sci/R&D Officer | - | - |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Steven Glazer
Former positions of Steven Glazer
| Companies | Position | Start | End |
|---|---|---|---|
| CHOSA ONCOLOGY AB | Corporate Officer/Principal | - | - |
| IDOGEN AB (PUBL) | Sales & Marketing | - | - |
| ECTIN RESEARCH AB | Chief Tech/Sci/R&D Officer | 01/09/2019 | - |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Chief Tech/Sci/R&D Officer | - | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - | - |
| MENDUS AB | Director/Board Member | 26/10/2016 | - |
| Independent Dir/Board Member | 26/10/2016 | - | |
| ░░░░░ ░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Steven Glazer
| University of Copenhagen | Doctorate Degree |
Statistics
International
| Sweden | 8 |
| Denmark | 5 |
| Netherlands | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 6 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| MENDUS AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ECTIN RESEARCH AB | Health Technology |
| Private companies | 5 |
|---|---|
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Health Technology |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Commercial Services |
| Glazer Consulting Holding ApS |
- Stock Market
- Insiders
- Steven Glazer
- Experience
